Rasayan Labs launches AI-native drug discovery platform at ICT Mumbai

In an exciting development, Rasayan Labs has unveiled a groundbreaking AI-based platform to enhance computational chemistry and drug discovery initiatives. This innovative platform merges critical functions, including retrosynthesis and ADMET prediction, to optimize research efficiency. Free access will be granted to researchers at the Institute of Chemical Technology, marking a pivotal collaboration that seeks to dramatically reduce drug development timelines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KhXkoyt
via IFTTT